Program:
Update on TFR: (Timothy Hughes)

• ELN/NCCN recommendations for TFR
• Early BCR-ABL1 kinetics predictive for TFR
• Probability of sustained TFR based on halving time
• Precision medicine approach in CML: bioassay-directed management
• Common questions regarding TFR

Global patients' survey on TFR (Giora Sharf)

• The TFR4CML patients' research
• Where is TFR done globally?
• The phases of TFR
• Results from the global survey: reasons for stopping treatment, topics discussed with doctors, doctor support, withdrawal syndrom, psychological support, information gaps

Panel of experts:

• Professor Timothy Hughes
  SAHMRI/University of Adelaide (Australia)
• Giora Sharf
  Co-Founder of CML Advocates Network / CML patient (Israel)